Patents Represented by Attorney Donovan J. De Witt
  • Patent number: 3960449
    Abstract: Particle analyzing method and apparatus are provided for measuring the intensity of light scattered from a particle as a function of angle. Particles such as biological cells are contained in a stream for travel along a path which includes a scatter line along which the particles pass successively. A beam of collimated monochromatic radiation is directed onto the flow path, and detector means are provided having a radiation acceptance geometry whose projection intercepts the beam along the scatter line. The projected acceptance geometry includes an aperture image located adjacent the scatter line and having a dimension in the direction of travel of the particles which is substantially less than the length of the scatter line such that the angle of scatter radiation detectable by the detector means varies according to the position of the particle along the scatter line. The output from the detector provides a measure of the scatter light intensity versus angle characteristic of the particle.
    Type: Grant
    Filed: June 5, 1975
    Date of Patent: June 1, 1976
    Assignee: The Board of Trustees of Leland Stanford Junior University
    Inventors: Joseph G. Carleton, Richard G. Sweet
  • Patent number: 3960589
    Abstract: A chemical species, present in two oxidation states which differ from one another by one equivalent, is added to pigment materials to serve as a recombination center for alternately capturing electrons and holes produced by the pigment materials when they are subjected to ultraviolet light exposure.
    Type: Grant
    Filed: May 27, 1975
    Date of Patent: June 1, 1976
    Assignee: Stanford Research Institute
    Inventors: Stanley Roy Morrison, Thomas Freund
  • Patent number: 3954766
    Abstract: The compounds 4-carbethoxy-1,4-diazabicyclo[3.2.1]octane and 4-diethylcarbamyl-1,4-diazabicyclo[3.2.1]octane, said compounds having utility as antifilarial agents.
    Type: Grant
    Filed: July 9, 1975
    Date of Patent: May 4, 1976
    Assignee: Stanford Research Institute
    Inventors: David W. Henry, Priscilla A. Sturm
  • Patent number: 3952114
    Abstract: New compounds 4-methyl-1,4-cyclohexadiene-1-carboxaldehyde syn-oxime, 4-methoxymethyl-1,4-cyclohexadiene-1-carboxaldehyde syn-oxime, and 4-(1-methoxyethyl)-1,4-cyclohexadiene-1-carboxaldehyde syn-oxime, as well as the compound 1,4-cyclohexadiene-1-carboxaldehyde syn-oxime, are found to have a high degree of sweetness which is accompanied by very little off-taste. The compounds have good stability even in acid solution. They give no evidence of toxicity and can be employed in foods and beverages as synthetic sweetening ingredients.
    Type: Grant
    Filed: August 25, 1975
    Date of Patent: April 20, 1976
    Assignee: Stanford Research Institute
    Inventors: Edward M. Acton, Michael W. Lerom, Herbert Stone
  • Patent number: 3951980
    Abstract: Twelve analogs of diethylcarbamazine as prepared by acylation of 3- and 8-methyl-3,8-diazabicyclo[3.2.1]octane, 2-methyl-2,5-diazabicyclo[2.2.2]octane, and 2-methyl-2,5-diazabicyclo[2.2.1]heptane with diethylcarbamyl chloride, ethyl chloroformate, ethyl isocyanate, and cyclohexanecarbonyl chloride. These compounds are formally derived from diethylcarbamazine in possessing two- or one-carbon bridges over the piperazine ring. The compounds have utility as antifilarial agents and as bronchodilators.
    Type: Grant
    Filed: August 21, 1975
    Date of Patent: April 20, 1976
    Assignee: Stanford Research Institute
    Inventors: David W. Henry, Priscilla A. Sturm
  • Patent number: 3947445
    Abstract: Twelve analogs of diethylcarbamazine as prepared by acylation of 3- and 8-methyl-3,8-diazabicyclo[3.2.1]octane, 2-methyl-2,5-diazabicyclo[2.2.2]octane, and 2-methyl-2,5-diazabicyclo [2.2.1]heptane with diethylcarbamyl chloride, ethyl chloroformate, ethyl isocyanate, and cyclohexanecarbonyl chloride. These compounds are formally derived from diethylcarbamazine in possessing two- or one-carbon bridges over the piperazine ring. The compounds have utility as antifilarial agents and as bronchodilators.
    Type: Grant
    Filed: August 21, 1975
    Date of Patent: March 30, 1976
    Assignee: Stanford Research Institute
    Inventors: David W. Henry, Priscilla A. Sturm
  • Patent number: 3946052
    Abstract: 19-Norpregna-1,3,5(10)-trien-3-ol and loweralkyl homologs thereof wherein the alkyl group attached in the 17.beta. position contains from 2 to 7 carbon atoms. Said compounds, along with the corresponding known 17.beta.-methyl derivative, are found to have antifertility activity, and particularly postcoital antifertility activity, along with very low estrogenic activity, when administered orally to mammals.
    Type: Grant
    Filed: June 16, 1975
    Date of Patent: March 23, 1976
    Assignee: Stanford Research Institute
    Inventors: David F. Crowe, Richard H. Peters, Masato Tanabe, George Detre
  • Patent number: 3940383
    Abstract: New 3-methyl-3-nitrosoureido derivatives of the following amino sugars were prepared as analogs of streptozotocin with the anomeric carbon protected, by nitrosating the methylureas in water with N.sub.2 O.sub.3 : 3-amino-3-deoxy-1,2-O-isopropylidene-.alpha.-D-ribofuranose; methyl 3-amino-3-deoxy-.beta.-D-xylopyranoside; methyl 3-amino-3-deoxy-.alpha.-D-altropyranoside; methyl 3-amino-3-deoxy-.alpha.-D-glucopyranoside; and methyl 3-amino-2,3,6-trideoxy-.alpha.-L-lyxohexopyranoside. Tests against murine leukemia L1210 show that the anticancer activity of streptozotocin not only was retained but was enhanced in most of these derivatives.
    Type: Grant
    Filed: December 12, 1974
    Date of Patent: February 24, 1976
    Assignee: Stanford Research Institute
    Inventors: Allan N. Fujiwara, Edward M. Acton, David W. Henry